Rafferty Asset Management and
Alyeska Investment Group have reduced their stock holdings in
Healthpeak Properties, Inc. Conversely, various other firms including
OMERS ADMINISTRATION Corp,
Nomura Holdings Inc, and
Northwestern Mutual Wealth Management Co boosted their stakes in the company. Despite executive shifts, Healthpeak is focusing on a life sciences investment strategy providing
attractive value and growth catalysts. The post-earnings sell-off is thought to be overblown. Meanwhile, Healthpeak has maintained low
ESG emissions, exceeding its goals. The stock, which currently sits at a 52-week low, has a 7% yield and is considered by analysts to be a high-yield REIT with excellent value. With the firm expected to deliver dividends,
passive income from investments in the stock remains a strong draw. Healthpeak’s recent $500 Million Debt Offering will shape its
liquidity and growth strategy. Despite recent downgrades, analysts give the company a
moderate buy rating. There are also indications of a valuation disconnect given Healthpeak's strong assets and the company boasts strong operational momentum backed by 7% NOI growth.
Healthpeak Properties DOC News Analytics from Fri, 07 Feb 2025 08:00:00 GMT to Sat, 06 Sep 2025 20:18:43 GMT -
Rating 8
- Innovation 5
- Information 6
- Rumor -2
